Skip to main content
. 2015 Jul 30;15:726. doi: 10.1186/s12889-015-2003-z

Table 1.

Socio-demographic characteristics, risky injection and sexual behaviors and service utilization by male PWID by HIV, HCV and HIV-HCV co-infection status, Delhi (2012)

Total Sero-negative HIV mono-infected HCV mono-infected HIV & HCV co-infected
% (n) % (n) p-value1 % (n) p-value1 % (n) p-value1
Number of PWIDs 2,292 100.0 (916) 100.0 (146) 100.0 (781) 100.0 (449)
Prevalence of sero-infections (%) 40.0 6.4 34.1 19.6
Socio-demographic characteristics
Age (median, IQR) 29 (23, 37) 28 (23, 38.5) 26 (22, 35) 0.016 2 29 (24, 38) 0.873 2 30 (24, 35) 0.7722
Education 0.371 0.972
 Illiterate 47.6 (1090) 46.8 (429) 48.6 (71) 46.3 (361) 51 (229) 2.8; 0.246
 Class 1-6 27.6 (632) 27.4 (251) 30.8 (45) 27.6 (215) 27 (121)
 7 or higher 24.8 (569) 25.8 (236) 20.6 (30) 26.2 (204) 22.1 (99)
Marital status 0.112 0.545 0.043
 Married/cohabiting 34.7 (796) 36.7 (336) 30.1 (44) 34.8 (272) 32.1 (144)
 Never married 52.9 (1213) 52.6 (482) 54.1 (79) 53 (414) 53 (238)
 Divorced/widowed 12.4 (283) 10.7 (98) 15.8 (23) 12.2 (95) 14.9 (67)
Religion 0.921 <0.001 0.609
 Hindu 62 (1418) 58.5 (535) 58.9 (86) 69.5 (541) 57 (256)
 Non-Hindu 38 (870) 41.5 (380) 41.1 (60) 30.5 (237) 43 (193)
Regional origin 0.003 0.010 0.010
 Delhi 25.4 (580) 25.4 (232) 24.7 (36) 25.4 (198) 25.4 (114)
 3 states adjacent to Delhi 44.4 (1016) 39.9 (365) 53.4 (78) 46.2 (360) 47.4 (213)
 Others 30.2 (692) 34.7 (317) 21.9 (32) 28.4 (221) 27.2 (122)
Duration of residence in Delhi (median, IQR) 22 (15, 30) 22 (15, 30) 20 (12, 29) 0.142 2 23 (16, 30) 0.124 2 23 (15, 30) 0.208 2
Accommodation 0.183 0.879 0.801
 Living at home with family 44 (1009) 44.4 (407) 39.7 (58) 44.4 (347) 43.9 (197)
 Living In rented/paying guest 17.5 (400) 17.6 (161) 14.4 (21) 18.4 (144) 16.5 (74)
 Living on the street 38.5 (883) 38 (348) 45.9 (67) 37.1 (290) 39.6 (178)
Comprehensive HIV knowledge 0.190 0.908 0.048
 No/incomplete knowledge 63.2 (1448) 64.5 (591) 58.9 (86) 64.8 (506) 59 (265)
 Complete knowledge 36.8 (844) 35.5 (325) 41.1 (60) 35.2 (275) 41 (184)
Alcohol use 0.046 0.859 0.009
 Never 54.4 (1246) 51.9 (475) 61 (89) 53.1 (414) 59.8 (268)
 2 times/week or less 35.6 (815) 37.1 (339) 33.6 (49) 35.8 (279) 33 (148)
 3 times a week or more 10 (228) 11 (101) 5.5 (8) 11.2 (87) 7.1 (32)
Sex with regular or paid/non-regular female partner in last 3 months 0.008 0.110 <0.001
 No sex 63.5 (1455) 57.6 (528) 71.2 (104) 62.6 (489) 74.4 (334)
 Safe sex 11 (251) 12.3 (113) 8.2 (12) 10.5 (82) 9.8 (44)
 Unsafe sex 25.6 (586) 30 (275) 20.6 (30) 26.9 (210) 15.8 (71)
Service utilization in the last 3 months
Accessed NSP services <0.001 <0.001 <0.001
 No 55.5 (1271) 70.4 (645) 43.2 (63) 48.9 (382) 40.3 (181)
 Yes 44.6 (1021) 29.6 (271) 56.9 (83) 51.1 (399) 59.7 (268)
Accessed detox/rehab services 0.696 0.270 0.148
 No 94.1 (2157) 93.3 (855) 92.5 (135) 94.6 (739) 95.3 (428)
 Yes 5.9 (135) 6.7 (61) 7.5 (11) 5.4 (42) 4.7 (21)
Accessed OST services 0.847 0.643 0.583
 No 89.3 (2046) 89.2 (817) 89.7 (131) 89.9 (702) 88.2 (396)
 Yes 10.7 (246) 10.8 (99) 10.3 (15) 10.1 (79) 11.8 (53)
Duration and frequency of injection drug use
Time since first injection <0.001 <0.001 <0.001
 1 year or less 13.2 (299) 22.5 (204) 9.7 (14) 8.6 (66) 3.4 (15)
 2-5 years 53.8 (1221) 52.7 (478) 54.5 (79) 55.1 (425) 53.6 (239)
 6-10 years 21.6 (490) 15.9 (144) 27.6 (40) 22.5 (174) 29.6 (132)
 11 years or more 11.5 (260) 8.9 (81) 8.3 (12) 13.9 (107) 13.5 (60)
Number of days injected in the past month <0.001 <0.001 <0.001
 Not injected 26.5 (606) 44.4 (406) 19.2 (28) 15.7 (122) 11.1 (50)
 1-10 days 20.5 (470) 23.5 (215) 16.4 (24) 18.2 (142) 19.8 (89)
 11-20 days 16.7 (382) 11.4 (104) 17.1 (25) 21.2 (165) 19.6 (88)
 21-30 days 36.3 (830) 20.7 (189) 47.3 (69) 44.9 (350) 49.4 (222)
Risky injection behavior in the past 1 month <0.001 <0.001 <0.001
 No risk 47.6 (1090) 63.7 (583) 39 (57) 37.6 (294) 34.7 (156)
 At least one risky injection 52.4 (1202) 36.4 (333) 61 (89) 62.4 (487) 65.3 (293)
Prior HIV test
Prior knowledge of own HIV status 0.001 0.778 <0.001
 Know the result 71.4 (1631) 74.5 (681) 61 (89) 73.9 (575) 64.1 (286)
 Not tested/ Result not known 28.6 (653) 25.5 (233) 39 (57) 26.1 (203) 35.9 (160)

1 Chi-squared test, unless specified, for each infection category compared with sero-negative participants

2 Mann–Whitney U test for each infection category compared with sero-negative participants

NSP: Needle Syringe Program; OST: Oral Substitution Therapy